BioAlliance Pharma Receives a Guarantee From Coface to Finance Its Export Activities

Published: Jan 03, 2013

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the signature of an assurance prospection agreement with Coface granting a guarantee to finance its export activities.

Back to news